|
|
 |
|
Viewing report
|
|
|
|
Cell Therapy Commercialization - Applying Stem Cell and Related Strategies
Drug and Market Development Publishing, Jan 2006
Traditionally, treatment of human diseases is carried out by small or large molecules that modulate specific cell types. In the majority of the cases, such as cancer, the aim of the treatment is to kill cancer cells, leading to the physiological benefit of the organism. In other circumstances, the disease cells are manipulated to perform a specific function that they normally do not. A variety of therapeutic molecules have been utilized to carry out for treatment leading to therapeutic benefit. These include small molecules, peptides, proteins, antibodies, anti-sense RNAs, and ribozymes. In the case of cell therapy, as the name indicates, treatment is carried out with cells instead of small molecules, as mentioned above. In cell therapy, cells are given to the patient as the therapeutic delivery system for a specific disease to achieve therapeutic benefit.
Report Overview
Cell Therapy Commercialization: Applying Stem Cell and Related Strategies provides a detailed background on cell therapy strategies currently in place as well as an analysis of future prospects. It provides a detailed breakdown of the steps involved in the stages of cell therapy with an extra emphasis on stem cells. A detailed forecast and analysis of the market is provided as well as an overview of the current news in the cell therapy field. Interviews with industry experts provide a first hand look at what is current in the cell therapy area. Also included is an analysis of current cell therapy patents.
Receive answers to crucial questions such as:
- What is the current status of the cell therapy market?
- What is the therapeutic potential of cell therapy?
- What strategies are used in cell therapy?
- Which cell therapy strategies are making headlines?
- What are the major and minor steps required for the success of cell therapy.
- Who are the current players and forces driving cell therapy?
- What is the science behind cell therapy?
About the Author
Dr. Anil Sehgal obtained his Ph.D. in Biomedical Sciences in 1994 from a Joint Program between Old Dominion University and Eastern Virginia Medical School. He served as Assistant Member at the Pacific Northwest Cancer Foundation in Seattle before joining UCSF. He initiated a molecular marker program in brain tumor area at UCSF. He has published over 20 publications and presented in numerous National and International Conferences. He also holds several patents in the area of markers and targets for cancer therapeutics. He recently served as Director of Molecular Biology and Genomics at ChemGenex Therapeutics. He is currently working as a consultant for start up companies.
Customers who bought this item also bought
Cell Therapy - Technologies, Markets and Companies
Cancer Cell Therapy Markets
Cell Therapy Markets
Stem Cell Research in Cardiology
Stem Cell Research 2008
Stem Cell Markets
Developments in Stem Cell Research
Understanding Stem Cell Research
Market Analysis –The Emergence of Stem Cell Research and Therapy
Opportunities in Human Embryonic Stem Cell (hESC) Products
The Stem Cell Report and Stem Cell Summit Webcast
US Stem Cell Market Analysis
|
|
|
|
